Italian Validation of a Tool for Assessing Sexual Function After Breast Cancer, FSFI-BC
Italian Validation for the Female Sexual Function Index for Breast Cancer Patients (FSFI-BC)
1 other identifier
observational
600
1 country
1
Brief Summary
This is a validation study of the italian language for the Female Sexual Function Index-Breast Cancer questionnaire. The validation of the instrument in Italian will allow the identification of possible issues related to sexual health and enable the provision of adequate medical and psychosexual counseling to these patients, both in clinical practice and in research studies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 19, 2020
CompletedFirst Submitted
Initial submission to the registry
March 26, 2024
CompletedFirst Posted
Study publicly available on registry
April 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedApril 1, 2024
March 1, 2024
4.2 years
March 26, 2024
March 26, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Validation of the italian translation of Female Sexual Function Index-Breast Cancer questionnaire
The measure of internal consistency utilized is Cronbach's alpha (α). The comparison will be done between the estimated α in the Italian questionnaire and the α of the original work.
12 months
Study Arms (2)
Patients with breast cancer and age <=50 years
Patients with diagnosis of breast cancer and age \<=50 years
Patients with breast cancer and age >50 years
Patients with diagnosis of breast cancer and age \>50 years
Eligibility Criteria
Patients treated at European Institute of Oncology for a operable breast cancer between 2012 and 2020
You may qualify if:
- Women with operable breast cancer;
- Operated on between 2012 and 2020;
- Randomly selected from the institutional database; 18 years of age (Age stratification: equally represented women aged \<50 years and women aged ≥50 years);
- Signing of the informed consent.
You may not qualify if:
- Severe psychiatric or cognitive illness;
- Ongoing psychological treatment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
European Institute of Oncology
Milan, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gabriella Pravettoni
European Institute of Oncology
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 26, 2024
First Posted
April 1, 2024
Study Start
October 19, 2020
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
April 1, 2024
Record last verified: 2024-03